Grasshopper, Sinocare told J&J last December and J
Post# of 11802
(Total Views: 385)
Posted On: 03/17/2018 10:39:16 AM
Re: Wheelhorse #4370
Grasshopper, Sinocare told J&J last December and January that all three (collectively) of its diabetic properties were worth $3 billion. J&J said no, they wanted $4 billion for the collection. Sinocare was apparently the only group bidding.
So to change the M&A environment, J&J enlists Platinum to propose $2.1 billion for Lifescan alone. Smart move, but risky. In fact the same move J&J made in 2015 with its Ortho property.
I do not think this stunt will scare up any new offers, but I might be wrong. And if Sinocare is going to up its offer for the three J&J properties, I think their December-January $3 billion offer may be raised to $3.05 or $3.1 billion. Will it be worth it? I am not sure.
So to change the M&A environment, J&J enlists Platinum to propose $2.1 billion for Lifescan alone. Smart move, but risky. In fact the same move J&J made in 2015 with its Ortho property.
I do not think this stunt will scare up any new offers, but I might be wrong. And if Sinocare is going to up its offer for the three J&J properties, I think their December-January $3 billion offer may be raised to $3.05 or $3.1 billion. Will it be worth it? I am not sure.
(2)
(1)Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼